Caffeine And Sodium Benzoate Injection, Solution
Product Images NDC 0517-2502

This is a single dose vial containing 250 mg/mL of Caffeine and Sodium Benzoate. Each mL provides 125 mg/m Caffeine with added ingredients to increase solubility. It is for intramuscular or slow intravenous use and is a prescription-only medication. The manufacturer is Regent, Inc., located in Shirley, NY with NDC 0517-2502-01. The document was last revised in September 2017.*

This is an injectable solution with the primary active ingredient Caffeine, packed in a single dose vial, and authorized for intramuscular or slow intravenous use with a prescription. Each milliliter provides 125mg of Caffeine with 125mg of Sodium Benzoate intended to improve solubility. It also contains sterile water, and pH is adjusted utilizing Hydrochloric Acid and/or Sodium Hydroxide. The solution is non-pyrogenic and may be saved at a temperature range of 20°C-25°C (68°F-77°F). Excursions of up to 15°C-30°C (59°F-86°F) are allowed. The package insert has details on proper administration. This product is produced and distributed by American Regent, Inc., in Shirley, NY.*

This is a product label with information on lot number, expiration date, and product identification numbers. The lot number is 0000 and the expiration date is January 1999. The product is identified by its GTIN (Global Trade Item Number) of 00305172502100 and a serial number of 3.*